Avidity
Harumi Parnell is a seasoned professional in Trial Master File (TMF) management with extensive experience in clinical operations. Currently serving as Manager of Trial Master File at Avidity Biosciences, Inc. since September 2024, Parnell previously held roles such as Manager of TMF Operations at inSeption Group and Senior TMF Specialist at EQRx, where responsibilities included ensuring TMFs were inspection-ready and maintaining document quality. Parnell's earlier positions include Senior Clinical Trial Assistant at Biosplice Therapeutics and Assessment Scientist at Syneos Health Clinical Solutions, demonstrating a consistent focus on quality assurance and training across various clinical trial processes. Parnell holds a M.Ed. in Early Childhood Intervention from Kent State University and a B.S. in Music Therapy from Saint Mary-of-the-Woods College.
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.